Investigational Drug Information for troriluzole
✉ Email this page to a colleague
What is the development status for investigational drug troriluzole?
troriluzole is an investigational drug.
There have been 10 clinical trials for troriluzole.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 8th 2019.
The most common disease conditions in clinical trials are Disease, Obsessive-Compulsive Disorder, and Compulsive Personality Disorder. The leading clinical trial sponsors are Biohaven Pharmaceuticals, Inc., Cytel Inc., and Biohaven Pharmaceutical Holding Company Ltd.
There are twenty-three US patents protecting this investigational drug and thirty-three international patents.
Summary for troriluzole
| US Patents | 23 |
| International Patents | 33 |
| US Patent Applications | 80 |
| WIPO Patent Applications | 38 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2019-03-08) |
| Vendors | 33 |
Recent Clinical Trials for troriluzole
| Title | Sponsor | Phase |
|---|---|---|
| Methamphetamine and Troriluzole | National Institute on Drug Abuse (NIDA) | EARLY_PHASE1 |
| Methamphetamine and Troriluzole | University of Kentucky | EARLY_PHASE1 |
| A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma | Biohaven Pharmaceuticals, Inc. | EARLY_PHASE1 |
Clinical Trial Summary for troriluzole
Top disease conditions for troriluzole
Top clinical trial sponsors for troriluzole
US Patents for troriluzole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| troriluzole | ⤷ Start Trial | Riluzole prodrugs and their use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Start Trial |
| troriluzole | ⤷ Start Trial | Prodrugs of riluzole and their method of use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Start Trial |
| troriluzole | ⤷ Start Trial | Riluzole prodrugs and their use | Biohaven Therapeutics Ltd | ⤷ Start Trial |
| troriluzole | ⤷ Start Trial | Riluzole prodrugs and their use | Biohaven Therapeutics Ltd | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for troriluzole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| troriluzole | Australia | AU2016226463 | 2035-03-03 | ⤷ Start Trial |
| troriluzole | Australia | AU2020233650 | 2035-03-03 | ⤷ Start Trial |
| troriluzole | Australia | AU2022202163 | 2035-03-03 | ⤷ Start Trial |
| troriluzole | Brazil | BR112017018832 | 2035-03-03 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
